[Initial results of clinical compatibility testing of antihuman lymphocyte globulin (AHLG-Dessau)].
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001792:Blood Platelets; D001794:Blood Pressure; D001831:Body Temperature; D004796:Clinical Enzyme Tests; D003109:Colonic Diseases, Functional / Q000188:drug therapy; D004361:Drug Tolerance; D004906:Erythrocyte Count; D006452:Hemoglobinometry; D006736:Horses / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008214:Lymphocytes; D009103:Multiple Sclerosis / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy; D011674:Pulse; D012507:Sarcoidosis / Q000188:drug therapy
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G
Erste Ergebnisse der klinischen Verträglichkeitstestung von Antihumanlymphozytenglobulin (AHLG-Dessau.